should include the Optovue OCT iWellness Examination that allows for early detection of various ocular diseases that may go undetected with ordinary testing. Recognizing subtle ocular changes is always in your best interest. Early detection means early treatment, and, hopefully, reduced vision loss. Comparable to your annual dental X-rays, this simple test should be performed annually regardless of symptoms. The iWellness Examination is an eligible expense for Flexible Spending Accounts.
Through the use of advanced instrumentation, diseases of the optic nerve, such as glaucoma, and the central retina, such as macular degeneration and diabetic retinopathy, have become easier to detect.
The Optovue OCT is the next generation of Scanning Ophthalmoscopes. It is a non-invasive test that produces a cross-sectional view of the retina. The results are similar to a CT-scan or MRI but without the use of a laser or X-rays. Once a problem is detected with the iWellness Examination, or if you already have a damaging eye disease, the complete Optovue OCT examination will be performed. Following the progressive changes in the status of your disease over time is a very important step in your continuing care.
By using Visual Evoked Potential technology, we can measure the electrical activity in the entire vision system, from the front of the eye to the visual cortex of the brain. And the patient does not have to say a word. The concept is similar to an EEG or EKG, but the VEP measures the electrical impulse between the eye and the brain.
The Diopsys NOVA-VEP Vision Testing System is a painless, non-invasive vision test that objectively measures the strength of the signal between the eyes and the brain, and how long it takes the signal to get there.
VEP has been demonstrated to aid in the diagnosis and treatment of many disorders including amblyopia, brain injury, stroke, glaucoma, multiple sclerosis, and other vision-related issues.
We are now able to determine how your eyes communicate with your brain in a way that no other instrument or vision test can.
Your cornea is your window to the world. It is the clear front, outer, layer of the eye, and is the most important focusing element of the visual system. The cornea consists of several layers and you must keep these layers healthy to maintain clear vision.
The Konan Specular Microscope is the first clinical instrument to allow us to look at the endothelium in very high detail. Early detection is important to maintaining corneal health.
Symptoms of corneal endothelial cell damage include morning blur that may clear after several minutes to several hours. Or light sensitivity, or photophobia, that is often noted when in a car at night. If the problems are not resolved, your corneal health can continue to decline.
One of every five people over age 65 in the U.S. has age-related macular degeneration (AMD), the leading cause of blindness in people over 50. It may cause blindness in about 20% of affected people if not managed correctly.
Foresee PHP is the first comprehensive solution for detecting and monitoring the progress of AMD including the dangerous "wet" stage that generally does not exhibit symptoms at its early phase.
Most people suffer from "dry AMD". This form progresses slowly and generally does not result in severe vision loss. Many people notice nothing, and will just add more light for reading.
In wet AMD, tiny blood vessels beneath the retina surface grow out of control. The resulting damage from the fluid leakage can be devastating, and leads to rapid, severe, and permanent central vision loss.
Regular testing with Foresee PHP can let us know if your AMD is progressing to the severe wet form of the disease before you experience the first visual symptoms. This can help save your vision.
Computerized digital images of your retina enable us to detect and make an early diagnosis of many abnormal conditions.
With this advancing technology, we are able to compare the initial images of the inside of your eyes with those images that we take in the future. Diabetes, hypertension, glaucoma, macular degeneration, brain tumor, and stroke may all be detected through retinal imaging. Subtle changes can be easily discovered, and if required, early treatment can be instituted.
Retinal imaging is also important if there is a family history of these diseases, as early detection may help to prevent future vision or health problems.
Medical insurance typically will cover the cost for retinal imaging only when there is an existing eye disease. All screening imaging is non-reimbursable by your insurance.
Over 1.5 million nerves are located at the macula, a pinhead size area, that is the nerve center of the eye. Damage to the macula is known as Age-related Macular Degeneration (AMD or ARMD), the leading cause of blindness in Americans over the age of 65. The risk of AMD significantly increases with age. Over age 65, one in five people has AMD. Over age 75, the number increases to one in three.
The Age-Related Eye Disease Study (AREDS), a ten-year clinical research study by the National Eye Institute released in 2001, proved that a specific formula of antioxidant vitamins slowed the progression of AMD by 25 percent. AREDS-2, the second phase of this study, has now been completed. The recommended AREDS-2 dosage is found in three daily Viteyes capsules. This new formula is now available at our office.
Not all Omega-3 products are equal. Many manufacturers use synthetic formulations that are not readily absorbed.
Dry Eye Omega Benefits is formulated to help address and alleviate the irritation and discomfort associated with dry eye syndrome and meibomian gland dysfunction.
Research has shown that Omega-3's are crucial in relieving the swelling in the lacrimal glands of the eyelids. This inflammation can lead to meibomitis and chronic lid disease.
Effective against a wide range of microorganisms. There are no extraneous buffers, preservatives, and surfactants. Avenova is gentle, refreshing, and soothing for everyday eyelid and eyelash cleansing. Avenova is the only daily lid and lash hygiene product with Neutrox (pure hypochlorous acid), a compound that is produced and released by the neutrophil cells, part of the body's natural defense mechanism against pathogens. Most patients will see noticeable results in less than 2 weeks.